BRIGHTVIEW XCT PDF
Find out about the Philips BrightView XCT system for SPECT/CT scanning at the Cancer Center of Santa Barbara. Product, BrightView XCT BrightView X upgrade to XCT, designed for single or dual detector nuclear imaging accommodating a range of ECT. Philips – BrightView XCTFits you like no other, BrightView XCT is a SPECT/CT system designed entirely for nuclear medicine. We took a deeper understanding .
|Published (Last):||23 May 2014|
|PDF File Size:||4.62 Mb|
|ePub File Size:||5.30 Mb|
|Price:||Free* [*Free Regsitration Required]|
The system represents the first time a flat panel X-ray detector will be used for CT imaging in nuclear medicine.
The BrightView XCT features technological advances that can enable low patient dose levels, high-resolution localization and high-quality attenuation correction with the potential for fewer artifacts and shorter exam times. This offers clinical advantages particularly in cardiology studies, the top procedure in nuclear medicine. Reduced movement can help improve patient comfort and allow for more confidence in image registration, the process of comparing, matching and superimposing the SPECT and CT images on one another for analysis.
The system combines Philips time-of-flight PET imaging technologies with its Brilliance CT Big Bore simulation to optimize oncology workflow, accuracy and patient experience.
The xcy allows patients to be positioned for simulation in the same manner as they would to receive therapy. Stereotactic Breast Imaging Technology Report: Digital Radiography Technology Report: Greg Freiherr Events About.
Technology October 07, News Artificial Intelligence December 04, Mirada Medical Joins U. Consortium Exploring Healthcare AI.
Mirada Medical, briightview leading global brand xft medical imaging software, will form part of an artificial intelligence AI News Teleradiology November 25, State of the Industry: Medical Hybrid Imaging Market. September 26, — Bruker recently announced the introduction of the new preclinical Technology Nuclear Imaging July 16, IMV, part of the Science and Medicine Group and a market research and business intelligence provider to the imaging Siemens Healthineers will announce U.
News Prostate Cancer June 13, A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission